D 4 -Symmetric Dirhodium Tetrakis(binaphthylphosphate) Catalysts for Enantioselective Functionalization of Unactivated C-H Bonds.
Ziyi ChenKristin ShimabukuroJohn BacsaDjamaladdin G MusaevHuw M L DaviesPublished in: Journal of the American Chemical Society (2024)
Dirhodium tetrakis(2,2'-binaphthylphosphate) catalysts were successfully developed for asymmetric C-H functionalization with trichloroethyl aryldiazoacetates as the carbene precursors. The 2,2'-binaphthylphosphate (BNP) ligands were modified by introduction of aryl and/or chloro functionality at the 4,4',6,6' positions. As the BNP ligands are C 2 -symmetric, the resulting dirhodium tetrakis(2,2'-binaphthylphosphate) complexes were expected to be D 4 -symmetric, but X-ray crystallographic and computational studies revealed this is not always the case because of internal T-shaped CH-π and aryl-aryl interactions between the ligands. The optimum catalyst is Rh 2 ( S -megaBNP) 4 , with 3,5-di( tert -butyl)phenyl substituents at the 4,4' positions and chloro substituents at the 6,6' positions. This catalyst adopts a D 4 -symmetric arrangement and is ideally suited for site-selective C-H functionalization at unactivated tertiary sites with high levels of enantioselectivity, outperforming the best dirhodium tetracarboxylate catalyst developed for this reaction. The standard reactions were conducted with a catalyst loading of 1 mol % but lower catalyst loadings can be used if desired, as illustrated in the C-H functionalization of cyclohexane in 91% ee with 0.0025 mol % catalyst loading (29,400 turnover numbers). These studies further illustrate the effectiveness of donor/acceptor carbenes in site-selective intermolecular C-H functionalization and expand the toolbox of catalysts available for catalyst-controlled C-H functionalization.
Keyphrases
- highly efficient
- room temperature
- metal organic framework
- ionic liquid
- reduced graphene oxide
- carbon dioxide
- visible light
- randomized controlled trial
- systematic review
- high resolution
- gold nanoparticles
- staphylococcus aureus
- escherichia coli
- computed tomography
- mass spectrometry
- single cell
- cystic fibrosis
- postmenopausal women
- bone mineral density
- quantum dots